Literature DB >> 1568170

Cytogenetic findings in liposarcoma correlate with histopathologic subtypes.

C Sreekantaiah1, C P Karakousis, S P Leong, A A Sandberg.   

Abstract

The cytogenetic findings in 31 liposarcomas from 26 patients are reported. Four other tumors did not grow. Three histologic types are represented in this analysis. The well-differentiated liposarcomas were characterized by telomeric associations, large marker chromosomes and ring chromosomes, and in some cases, double minutes. The pleomorphic liposarcomas contained very high clonal chromosomal numbers with near-tetraploid modes and numerous variable, often unidentifiable, chromosomal abnormalities. The myxoid liposarcomas were characterized primarily by a t(12;16)(q13;p11) as the sole abnormality or additional changes. These results indicate that cytogenetic findings may provide a new criterion, not only for establishing the diagnosis of liposarcoma, but also for differentiating confusing histologic types of liposarcoma and these lesions from other types of sarcomas.

Entities:  

Mesh:

Year:  1992        PMID: 1568170     DOI: 10.1002/1097-0142(19920515)69:10<2484::aid-cncr2820691017>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Induction of a secreted protein by the myxoid liposarcoma oncogene.

Authors:  M Kuroda; X Wang; J Sok; Y Yin; P Chung; J W Giannotti; K A Jacobs; L J Fitz; P Murtha-Riel; K J Turner; D Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  Protein Degradation and the Pathologic Basis of Disease.

Authors:  John Hanna; Angel Guerra-Moreno; Jessie Ang; Yagmur Micoogullari
Journal:  Am J Pathol       Date:  2018-10-10       Impact factor: 4.307

3.  Can radiomics improve the prediction of metastatic relapse of myxoid/round cell liposarcomas?

Authors:  Amandine Crombé; François Le Loarer; Maxime Sitbon; Antoine Italiano; Eberhard Stoeckle; Xavier Buy; Michèle Kind
Journal:  Eur Radiol       Date:  2020-01-17       Impact factor: 5.315

4.  Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.

Authors:  C R Antonescu; A Elahi; M Humphrey; M Y Lui; J H Healey; M F Brennan; J M Woodruff; S C Jhanwar; M Ladanyi
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

5.  Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153).

Authors:  X Z Wang; B Lawson; J W Brewer; H Zinszner; A Sanjay; L J Mi; R Boorstein; G Kreibich; L M Hendershot; D Ron
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

Review 6.  Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.

Authors:  C Sreekantaiah; M Ladanyi; E Rodriguez; R S Chaganti
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.

Authors:  C Orndal; N Mandahl; A Rydholm; H Willén; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities.

Authors:  I Sánchez-García; T H Rabbitts
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 9.  Lipomatous tumours of soft tissues: an update.

Authors:  T Mentzel; C D Fletcher
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.

Authors:  C D Fletcher; M Akerman; P Dal Cin; I de Wever; N Mandahl; F Mertens; F Mitelman; J Rosai; A Rydholm; R Sciot; G Tallini; H van den Berghe; W van de Ven; R Vanni; H Willen
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.